Answers are grounded in this paper and cite their sources.
An investigation has been carried out to find out the anti cancerous compounds can exhibit anti diabetic against aldose reductase.Diabetes and cancer are common diseases worldwide.In our study we have taken 17 anti cancerous compounds from inhouse chalcones database to perform docking studies.It reveals that there are some compounds which are binding with high affinity than the average docking score -126.048kcal/mol of ligands of the 1AH3 protein.The anti cancer compounds exhibit high docking score than the average -126.048kcal/mol.The anti cancer compound can be used as anti diabetic.
No takes yet. Share an insight, caveat, or question.
Muppalaneni et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: